126 related articles for article (PubMed ID: 2127395)
1. Recombination of the c-myc gene with IgH enhancer-S mu sequences in a murine plasmacytoma (DCPC21) without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Curr Top Microbiol Immunol; 1990; 166():267-78. PubMed ID: 2127395
[No Abstract] [Full Text] [Related]
2. c-myc gene in a murine plasmocytoma without visible chromosomal translocations moves to chromosome 12F1 with Pvt-1 and rearranges with IgH enhancer-S mu sequences.
Ohno S; Migita S; Murakami S
Int J Cancer; 1991 Aug; 49(1):102-8. PubMed ID: 1874562
[TBL] [Abstract][Full Text] [Related]
3. Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.
Thøger Andersen AS; Jensen AW; Grant P; Arulampalam V; Pettersson S; Junker S
Mol Immunol; 1997 Feb; 34(2):97-107. PubMed ID: 9188842
[TBL] [Abstract][Full Text] [Related]
4. Aberrant regulation of the IgH 3' enhancer by c-myc in plasmacytoma cells.
Arulampalam V; Grant P; Poellinger L; Pettersson S
Mol Immunol; 1995 Dec; 32(17-18):1369-75. PubMed ID: 8643106
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes.
Wiener F; Kuschak TI; Ohno S; Mai S
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13967-72. PubMed ID: 10570182
[TBL] [Abstract][Full Text] [Related]
6. Deletional remodeling of c-myc-deregulating chromosomal translocations.
Kovalchuk AL; Müller JR; Janz S
Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal product of a t(12;15) in murine plasmacytoma TEPC 1033:5' c-myc to IgH enhancer region.
Gilliam AC; Fell HP; Carayannopuolos L; Tucker PW
Nucleic Acids Res; 1989 Sep; 17(18):7533. PubMed ID: 2508064
[No Abstract] [Full Text] [Related]
8. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
9. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma.
Corcoran LM; Cory S; Adams JM
Cell; 1985 Jan; 40(1):71-9. PubMed ID: 2981633
[TBL] [Abstract][Full Text] [Related]
10. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
11. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
Taub R; Kirsch I; Morton C; Lenoir G; Swan D; Tronick S; Aaronson S; Leder P
Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7837-41. PubMed ID: 6818551
[TBL] [Abstract][Full Text] [Related]
12. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
Silva S; Wiener F; Klein G; Janz S
Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
[TBL] [Abstract][Full Text] [Related]
13. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.
Fahrlander PD; Sümegi J; Yang JQ; Wiener F; Marcu KB; Klein G
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3746-50. PubMed ID: 2987943
[TBL] [Abstract][Full Text] [Related]
14. Genomic instability in B-cells and diversity of recombinations that activate c-myc.
Janz S; Jones GM; Müller JR; Potter M
Curr Top Microbiol Immunol; 1995; 194():373-80. PubMed ID: 7895512
[TBL] [Abstract][Full Text] [Related]
15. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
16. Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.
Janz S; Kovalchuk AL; Müller JR; Potter M
Curr Top Microbiol Immunol; 1997; 224():241-50. PubMed ID: 9308247
[TBL] [Abstract][Full Text] [Related]
17. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
[TBL] [Abstract][Full Text] [Related]
18. Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction.
Janz S; Müller J; Shaughnessy J; Potter M
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7361-5. PubMed ID: 8346257
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin/Myc recombinations in murine Peyer's patch follicles.
Müller JR; Mushinski EB; Williams JA; Hausner PF
Genes Chromosomes Cancer; 1997 Sep; 20(1):1-8. PubMed ID: 9290947
[TBL] [Abstract][Full Text] [Related]
20. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
